As per our report published, the size of the Global Anticoccidial Drugs Market is expected to have a growth rate of 3.61% CAGR from 2020 to 2025. The market is anticipated to grow USD 1511 Million by 2024 end,
Coccidian protozoa cause coccidiosis. It is a parasitic disease in the intestinal tract of the animal. The disease spread from one animal to another by contact with infected tissue or faeces. Although most animals are asymptomatic with the spread of this infection; immuno-compromised animals may suffer from severity and death. Anticoccidial drugs are manufactured with hygienic measures which are used to prevent or control coccidiosis. Coccidiosis is a disease that damages mucosal and submucosal tissues in the intestinal tract for animals and birds.
Anticoccidial drugs are the agents used to treat, prevent and control coccidial infections. There is a risk of an increase in coccidiosis due to environmental factors and others such as contamination or other issues related to hygienic measures. Hence, there is an alarming increase in demand for newer anticoccidial drugs in the drug market. Increasing need to prevent the spread of diseases in animals with effective medication and the rise in the consumption rate of meat and poultry products are the primary reasons which are driving the growth of the global anticoccidial drugs market.
MARKET DRIVERS
The growing number of veterinary hospitals, rise in the demand to improve the quality of drugs with different techniques, growing disposable income in urban areas and people's concern towards maintaining a healthy diet are further helping the global anticoccidial drugs market to grow.
Additionally, growing support from the government through investments, the rising demand to increase the production rate of drugs with high quality, increasing concern towards animal’s health conditions across the world are further accelerating the market growth. Adoption of the latest technology, the launch of useful products and the rising number of infectious diseases among animals and birds are expected to fuel the growth opportunities for the anticoccidial drugs market.
MARKET RESTRAINTS
However, the lack of skilled persons in manufacturing appropriate drugs with correct dosage forms is slowly restricting the demand of the global anticoccidial drugs market. The availability of other drugs at a lower cost, fluctuations in the prices of final products due to less availability of raw materials are expected to limit the growth of the global anticoccidial drugs market.
REPORT COVERAGE
|
REPORT METRIC |
DETAILS |
|
Market Size Available |
2019 to 2025 |
|
Base Year |
2019 |
|
Forecast Period |
2020 to 2025 |
|
Segments Analysed |
By Drug Type, Animal Type and Region |
|
Various Analyses Covered |
Global, Regional & Country Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities |
|
Regions Analysed |
North America, Europe, Asia Pacific, Latin America, Middle East and Africa |
This research report on the global anticoccidial drugs market has been segmented and sub-segmented based on the drug type, animal type and region.
Anticoccidial Drugs Market Analysis - By Drug Type
By Drug Type, Ionophore anticoccidial drug type witnessed the highest shares of the market. Increasing research and development institutes to launch several various drugs are leveraging the demand of the market.
Antibiotic anticoccidials drug type is expected to grow at the fastest growth rate during the forecast period. The rise in the scale of research institutes to introduce certain types of drugs at high quality with the latest technology is creating a chance for the market to grow extensively. Also, the growing economy in almost every region is magnifying the demand of the market.
Anticoccidial Drugs Market Analysis - By Animal Type
Based on Animal Type, the Poultry animal type is leading with dominant shares of the market. The emergence of the latest techniques in manufacturing the drugs is prompting the demand of the market. Also, the rise in the incidences of coccidiosis, especially in food-producing animals, is surging the need of this market.
Anticoccidial Drugs Market Analysis - By Region
Regionally, the North American market is ruling the global anticoccidial drugs market with highest shares owing to the adoption of advanced techniques in manufacturing drugs. Also, the launch of innovative medicines that are in favour to produce the most top quality products is significantly influencing the demand of the Anticoccidial Drugs Market.
Asia pacific is following North America in holding dominant shares of the market with the rising population, growing demand for poultry products and increasing support from the government through funds. In addition to this, the market is also fuelled by the increasing scale of the pharmaceutical industries across the region.
Europe will be growing at a faster rate in foreseen years with the growing consumption rate of the meat.
The Middle East and Africa are deemed to have a prominent growth rate in the coming years.
TOP COMPANIES IN THE MARKET
Key companies operating in the global anticoccidial drugs market profiled in this report are Bayer Health care, Zoetis, Elanco, Merial, Merck Animal Healthcare, Ceva Santé Animale, Virbac, Boehringer Ingelheim Animal Health, Novartis Animal Healthcare and Smartvet Inc.
RECENT MARKET DEVELOPMENTS
On September 09, 2019, Virbac launched Multimin that is used for the cattle. This Multimin is a prescription-only for preventing imbalance or detoxify the harmful effects that can lead to tissue damage that affects the performance in cattle. This multi min is designed for managing during of high call in the dairy of beef cattle and dairies like breeding, calving and vaccination. Once the injection is done, it reached the blood and liver, and this is very quick, simple and accurate to improve the health of the cattle.
On May 08, 2020, Zoetis shows how suckling calves with significant weight gain from implants. It is a considerable increase in weaning weight.
On October 19, 2019, Ceva Sante Animale made an agreement with ProBioGen for the manufacture of representing as a transform of poultry vaccines with the help of ProBioGen’s proprietary AGE1.CR technology. AGE1 is a preserved cell line that is obtained from the duck. This cell line is created as a platform to restore chicken cells for the manufacture of vaccines related to poultry. Ceva and ProBioGen have a very long track in introducing new veterinary vaccines through different research and development programs.
Table of Contents of the report:
Related Reports
Feb 2020
Download Sample
Feb 2020
Download Sample
Feb 2020
Download Sample
Feb 2020
Download Sample
